Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
KCT0001977Phase 3Recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of somatostatin in hepatic failure, sponsored by Pharmbio Korea Inc. Started Feb 2016; status: recruiting.
02
Drugs
somatostatin
03
Conditions
hepatic failure
Beyond the preview
Go deeper on KCT0001977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001977.